IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
3.065
+0.040 (1.32%)
Aug 22, 2025, 5:29 PM CET
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 266.28 million as of August 29, 2025. Its market cap has decreased by -66.23% in one year.
Market Cap
266.28M
Enterprise Value
288.39M
Revenue
75.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.07
Market Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 266.28M, a decrease of -35.52%. That is a compound annual growth rate of -5.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 101.89B |
Sectra AB | 64.55B |
Getinge AB | 56.16B |
Camurus AB | 43.17B |
Medicover AB | 40.08B |
Asker Healthcare Group AB | 38.16B |
BioArctic AB | 27.36B |
AddLife AB | 21.53B |